Home > Healthcare > Medical Devices > Therapeutic Devices > Pain Management Devices Market

Pain Management Devices Market Trends

Report ID: GMI6125
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Pain Management Devices Market Trends

Chronic pain is often a long-term condition requiring ongoing management. Home-based pain management devices ensure continuity of care by providing consistent access to treatments and therapies without any disruptions. Homecare settings provide individuals with the convenience and comfort of managing their chronic pain in their own familiar environment. Home-based pain management devices offer potential cost savings compared to repeated visits to healthcare facilities and individuals can avoid expenses related to transportation, and other parameters. Furthermore, long-term use of pain management devices at home can be more cost-effective than ongoing clinic or hospital visits.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of pain management devices was valued at over USD 4.4 billion in 2023 and will reach around USD 9.5 billion by 2032, backed by the favorable reimbursement policies, technological advancements, growing aging population, and increasing prevalence of chronic pain.

The market share from neuropathic pain segment is projected to surpass around USD 2.8 billion by 2032, owing to the growing body of clinical evidence supporting the effectiveness of pain management devices in neuropathic pain management.

North America pain management devices market is anticipated to cross around USD 4 billion by 2032, attributed to a well-developed and advanced healthcare infrastructure with state-of-the-art hospitals, clinics, and research institutions in the region.

Boston Scientific Corporation, Medtronic plc, B. Braun Melsungen AG, Stryker Corporation, Abbott Laboratories, Stim Wave Technologies, and Nevro Corporation among others.